Women OK with Pharmacists Prescribing Hormonal Contraception
Drug Topics
DECEMBER 6, 2022
Faced with access problems, women could be positively impacted by pharmacists having prescribing powers in New York state.
Tue.Dec 06, 2022
201 
2023 Pharmacy Forecast Predicts Artificial Intelligence Can Help Reshape Health-Systems
Pharmacy Times
DECEMBER 6, 2022
Increasing workplace diversity, addressing health disparities, and overcoming disruptions from COVID-19 are considered top goals among pharmacy stakeholders.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharmacist Intervention Improves Clinical Outcomes in Patients with Diabetes
Drug Topics
DECEMBER 6, 2022
Diabetes self-management education and diabetes prevention programs can improve patient outcomes including mental health and HbA1C.
Opinion: Victims of domestic abuse should get the same top-notch concussion care as athletes
STAT
DECEMBER 6, 2022
Two vastly different experiences — serving as a “guest coach” on the sidelines for a Division I football team and volunteering in a busy emergency department — showed me just how unequal and damaging the lack of care provided for women who are victims of domestic violence can be. In the first decade of the 2000s, one of the benefits of being a professor at Wake Forest University was the opportunity I received nearly every year to serve as a guest coach.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Creating A Career Ladder for Pharmacy Technicians
Drug Topics
DECEMBER 6, 2022
Developing more advanced roles for pharmacy technician can reduce turnover in roles.
Successful Career Ladder Helps Retain Pharmacy Technicians
Pharmacy Times
DECEMBER 6, 2022
Tom Greenlee, retail pharmacy manager at the University of Missouri Health Care, and Kayla Hodges, 340B Analyst in Pharmacy Business at the University of Missouri Health Care, discusses how a successful career ladder can help retain pharmacy technicians.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Expert Discusses What Pharmacists Should Know About Herbal Supplements for Dementia
Pharmacy Times
DECEMBER 6, 2022
Kalin Clifford, associate professor in the Geriatrics Division at Texas Tech University Health Sciences Center in the Jerry H. Hodge School of Pharmacy, discusses the potential benefits of herbal supplements for dementia care.
Biosimilars Create Significant Saving for Providers, Payors, and Patients
Drug Topics
DECEMBER 6, 2022
Biosimilars have the potential to create immense savings.
Study Emphasizes Need for Long-Term Monitoring of Hypertension After Childbirth
Pharmacy Times
DECEMBER 6, 2022
Nearly half of the study population received a first-time hypertension diagnosis post hospitalization, with approximately half of these new cases occurring more than 6 weeks postpartum.
Apple scores victory in dispute over heart monitoring technologies in Apple Watch
STAT
DECEMBER 6, 2022
In a significant victory, Apple has successfully challenged patents at the center of a high-profile dispute with medical device company AliveCor. The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board, or PTAB, on Tuesday ruled that three AliveCor patents covering heart monitoring technologies for wearable devices were unpatentable.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Healthy Plant-based Diet Found to Lower Colorectal Cancer Risk in Men
Pharmacy Times
DECEMBER 6, 2022
A recent study did not find a significant association between a healthy plant-based diet and the risk for colorectal cancer among 93,475 US women.
Nkarta data supports natural killer cells in cancer treatment
Pharmafile
DECEMBER 6, 2022
San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is as-yet unproven but appears hopefully at this early stage. Nkarta has just reported results from an early-stage trial of its CAR-NK therapies, which looks likely to generate enthusiasm to this area of research. read more.
Study: Black Adults Experienced Early Signs of Brain Aging Faster Than Other Racial, Ethnic Minority Groups
Pharmacy Times
DECEMBER 6, 2022
White adults in their midlife showed slower brain aging than Black and Latinx individuals, but between mid- and late life, they showed increased signs of aging.
Psychedelic therapy is moving to the next frontier: workplace perk
STAT
DECEMBER 6, 2022
Acupuncture and chiropractic care weren’t always the common fixtures of employer benefit plans they are today. It took clamoring from workers, the accumulation of evidence, and the slow realization by businesses that those perks would be popular with workers. A similar evolution could be in store for psychedelic-assisted therapy for mental health conditions.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
2-Drug Regimen Shows Benefit in Treatment of HIV
Pharmacy Times
DECEMBER 6, 2022
Dena Dillon, HIV clinical pharmacy specialist at the University of Iowa Health Care, discusses 2-drug regimens for individuals living with HIV.
Opinion: Pediatricians and parents on the brink: This is their March 2020
STAT
DECEMBER 6, 2022
In March 2020, as the Covid-19 pandemic swept across the United States, the nation’s pediatric providers and pediatric units immediately pitched in to treat adults sickened by this then-mysterious and deadly disease. But now that the pediatric community is facing its own March 2020 with the confluence of Covid-19, influenza, and respiratory syncytial virus (RSV), the response from outside this community has been slow.
ASHP Studies Find Patients Welcome Hormonal Birth Control Access from Pharmacists
Pharmacy Times
DECEMBER 6, 2022
A survey of women in New York confirmed that nearly three-quarters would be comfortable getting a contraceptive prescription from a pharmacist.
A new coalition aims to close AI’s credibility gap in medicine with testing and oversight
STAT
DECEMBER 6, 2022
To read the medical literature, you might think AI is taking over medicine. It can detect cancers on images earlier, find heart issues invisible to cardiologists, and predict organ dysfunction hours before it becomes dangerous to hospitalized patients. But most of the AI models described in journals — and lionized in press releases — never make it into clinical use.
Non-pharmacologic Interventions Not Viable in Stopping Spread of RSV, Flu Over Long Term
Pharmacy Times
DECEMBER 6, 2022
Interventions such as mask-wearing and social distancing have been found effective at limiting the spread of respiratory diseases.
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $805 million in 2021
STAT
DECEMBER 6, 2022
During 2021, drugmakers substantially raised prices on seven widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $805 million last year, according to a new report. The drug for which spending increased the most due to a price increase was Xifaxan, which is used to treat both irritable bowel syndrome and a complication of cirrhosis.
Partial Breast Stereotactic Radiation May Lead to Less Toxicity in Breast Cancer Treatment
Pharmacy Times
DECEMBER 6, 2022
A new radiation therapy may reduce toxicity compared to standard therapy, paving the way for a safer and possibly, more effective, treatment of early-stage breast cancer.
STAT+: Zantac lawsuits are tossed out as judge lambasts lack of evidence showing links to cancer
STAT
DECEMBER 6, 2022
Several big drugmakers — Sanofi, GSK, Pfizer and Boehringer Ingelheim — will not have to face thousands of lawsuits claiming the Zantac heartburn drug can cause cancer after a federal judge decided consumers’ claims were not backed by sound scientific evidence. In a 341-page ruling , U.S. District Court Judge Robin Rosenberg concluded that the consumer lawsuits relied on flawed science and were therefore unable to show legitimate links between the widely used medicine and se
10 Ways to Reduce Medication Errors at Your Pharmacy
Digital Pharmacist
DECEMBER 6, 2022
Medication errors have the potential to occur frequently and when we least expect them. Whether it be human error involved in filling the prescription or dispensing it, they can happen at any stage in the process. Below we are going to discuss ways to reduce medication errors at your pharmacy. 1. Avoid Multitasking. Juggling multiple tasks such as answering phone calls while handling drop-offs and also filling medication all at once may be “efficient” but can cause errors.
STAT+: ‘This is not a cure’: Consensus begins to emerge on new Alzheimer’s drug
STAT
DECEMBER 6, 2022
NEW YORK — A consensus may be emerging about how to prescribe the new Alzheimer’s drug lecanemab , according to remarks made by both a critic of other Alzheimer’s medicines and the CEO of the company that developed it. Ivan Cheung, the CEO of Eisai , the lecanemab developer, said at a STAT event Monday night that if patients carry a particular genetic variant that increases the risk of bleeding in the brain when taking the drug, they should only take the medicine if they and
Brexafemme Given Approval as Treatment for Recurrent Yeast Infections
Drug Topics
DECEMBER 6, 2022
Brexafemme is a non-azole oral antifungal now approved to both treat and prevent recurrent yeast infections in women.
STAT+: ‘Who is the real pioneer?’: Apple and AliveCor go head-to-head over crucial heart monitoring tech for smartwatches
STAT
DECEMBER 6, 2022
Two years after it accused Apple of copying its heart monitoring technology and putting it into millions of smartwatches, a small company called AliveCor may soon notch a fresh legal victory. But if you’re going to go to war with Apple, you’d better be ready to fight to the death. The allegations, raised in federal court and before the International Trade Commission, surround technologies AliveCor released in 2017 with the KardiaBand, a high-tech watchband that used the Apple Watch
UnitedHealth report: As mental health concerns rise, more providers are available to treat these needs
Fierce Healthcare
DECEMBER 6, 2022
UnitedHealth report: As mental health concerns rise, more providers are available to treat these needs. pminemyer. Tue, 12/06/2022 - 16:03.
STATUS List Spotlight: A Conversation with Otis Brawley
STAT
DECEMBER 6, 2022
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. This February, STAT published our first STATUS List. This annual project aims to be the most definitive accounting of impactful individuals in health, medicine, and science. Some are well-known as changemakers; others are largely unheralded heroes. But all have compelling stories to tell.
Despite Some Obstacles, Biosimilars Promise Enormous Cost Savings
Pharmacy Times
DECEMBER 6, 2022
Getting payers on board will be key to national biosimilar cost-savings potential.
STAT+: Karuna Therapeutics replaces its CEO, suggesting takeover unlikely soon
STAT
DECEMBER 6, 2022
Karuna Therapeutics said Tuesday that its CEO, Steve Paul, will be replaced by Bill Meury, a private equity investor and former pharmaceutical executive, suggesting a takeover is unlikely in the near future. Paul will remain with the company as chief scientific officer and a member of its board. Christopher Coughlin, the company’s lead independent director, will take Paul’s role as chair of the board.
Psoriasis With Coexistent Lupus Erythematosus Rare, Mainly Impacts Women
Pharmacy Times
DECEMBER 6, 2022
Psoriasis with coexistent lupus erythematosus is uncommon, shows a female preponderance, and is more likely to have joint involvement from both conditions.
STAT+: Gossamer drug for lung hypertension achieves study goal but with subpar treatment effect
STAT
DECEMBER 6, 2022
Gossamer Bio said Tuesday that its experimental drug for pulmonary arterial hypertension achieved the main goal of a mid-stage clinical trial. But the treatment effect was smaller than expected, raising concerns that the drug may not be potent enough to provide a meaningful benefit for patients. Shares of Gossamer fell 64% to $3 in early trading.
Evidence standard drawn up for digital therapeutics
pharmaphorum
DECEMBER 6, 2022
A model framework for generating the evidence to demonstrate the efficacy of digital therapeutics so they can secure regulatory approval and reimbursement has been published by a trade organisation representing digital health companies. The non-profit Digital Therapeutics Alliance (DTA) – working with clinical trials specialist Curebase – has drawn up the document to help encourage the development of DTx products and get them accepted in clinical practice.
STAT+: France’s drug regulator is under investigation for its handling of a thyroid drug
STAT
DECEMBER 6, 2022
France’s drug regulator is being investigated for issuing misleading information in connection with a thyroid treatment sold by Merck KGaA, and the move comes just weeks after an investigation was also opened into the company over the same allegation. The probe is the latest development in a widening drama that began five years ago when thousands of patients complained about severe side effects from a new formulation of the medicine, which is called Levothyrox and is used by an estimated
Let's personalize your content